U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX763093: GSM1548448: ICC18 (Exome-seq); Homo sapiens; OTHER
1 ILLUMINA (Illumina HiSeq 2500) run: 15.6M spots, 1.6G bases, 1.1Gb downloads

Submitted by: Gene Expression Omnibus (GEO)
Study: Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
show Abstracthide Abstract
Intrahepatic cholangiocarcinoma (iCCA) is a fatal bile duct cancer with dismal prognosis and limited therapeutic options. By performing RNA- and exome sequencing analyses we have discovered a novel fusion event, FGFR2-PPHLN1 (16%), and damaging mutations in the ARAF oncogene (11%). Overall design: Methods: mRNA and gDNA were exctracted from fresh frozen tumor tissues and corresponding normal tissue (n=8 pairs) from patients with iCCA who underwent surgical resection. RNA-seq was performed using Illumina HiSeq 2500 System with 100 nucleotide single-end reads. One sample and its paired non-tumoral tissue were eliminated from the subsequent analysis because of bad RNa quality. The same 8 paired tumors were also analyzed by whole-exome seq. *** Submitter confirms there are no patient privacy concerns with these data. ***
Sample: ICC18 (Exome-seq)
SAMN03199498 • SRS747603 • All experiments • All runs
Organism: Homo sapiens
Library:
Instrument: Illumina HiSeq 2500
Strategy: OTHER
Source: GENOMIC
Selection: other
Layout: SINGLE
Construction protocol: Total RNA was extracted from homogenized cholangiocarcinoma samples and their normal conterparts usingTRizol Regent (Invitrogen). Quantity of RNA was measured using Quant-iT Ribogreen RNA assay kit and quality was assessed using a Bioanalyzer. One µg of RNA was used for subsequent RNA-seq library generation. DNA was isolated using the ChargeSwitch® gDNA Mini Tissue Ki/t (Invitrogen) after tissue disruption with a homogenizer. DNA quantity was assessed through Quant-It PicoGreen dsDNA Assay kit (Invitrogen) and its integrity confirmed by agarose gel. For RNA-seq, the sequencing library was prepared with the standard TruSeq RNA Sample Prep Kit v2 protocol (Illumina, CA, USA). Briefly, total RNA was poly-A-selected and then fragmented. The cDNA was synthesized using random hexamers, end-repaired and ligated with appropriate adaptors for sequencing. The library then underwent size selection and purification using AMPure XP beads (Beckman Coulter, CA, USA). The appropriate Illumina recommended 6 bp barcode bases are introduced at one end of the adaptors during PCR amplification step. The size and concentration of the RNAseq libraries was measured by Bioanalyzer and Qubit fluorometry (Life Technologies, NY, USA) before loading onto the sequencer. The mRNA libraries were sequenced on the Illumina HiSeq 2500 System with 100 nucleotide single-end reads, according to the standard manufacturer's protocol (Illumina, CA, USA). For exome-seq, total genomic DNA library is generated following the manufacturer protocol (NEBNext DNA Library Prep Master Mix Set for Illumina, New England Biolabs, Ipswich, MA). For whole exome sequencing (WES), the library then undergoes solution-based hybridization to an oligonucleotide pool designed to enrich for the whole exome regions of interests. The library is captured by following the manufacturer protocol (SeqCap EZ Human Exome Library v3.0 User Guide. Roche NimbleGen. Madison, WI).
Experiment attributes:
GEO Accession: GSM1548448
Links:
External link:
Runs: 1 run, 15.6M spots, 1.6G bases, 1.1Gb
Run# of Spots# of BasesSizePublished
SRR165662915,601,3951.6G1.1Gb2015-01-22

ID:
1102112

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...